The mechanism of botulinum A on Raynaud syndrome

BACKGROUND: Botulinum neurotoxin type A (BoNT/A) is emerging as a treatment modality for Raynaud’s phenomenon (RP). However, the mechanism of the role of BoNT/A in antagonizing the constriction of arteriola in RP remains unclear. MATERIALS AND METHODS: We tested the constriction of arteriole diamete...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yanwen, Liu, Ying, Hao, Yunhua, Feng, Ya, Pan, Lizhen, Liu, Wuchao, Li, Bing, Xiao, Libin, Jin, Lingjing, Nie, Zhiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027706/
https://www.ncbi.nlm.nih.gov/pubmed/29983545
http://dx.doi.org/10.2147/DDDT.S161113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027706/
https://www.ncbi.nlm.nih.gov/pubmed/29983545
http://dx.doi.org/10.2147/DDDT.S161113

Ejemplares similares